Ann M. Miller's Insider Trades & SAST Disclosures
Ann M. Miller's most recent trade in Dutch Bros Inc - Ordinary Shares - Class A was a trade of 1,779 Restricted Stock Units done . Disclosure was reported to the exchange on May 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ann M. Miller.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 1,779 | 1,779 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 763 | 0 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 763 | 9,545 | - | 0 | Class A Common Stock | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 762 | 763 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 762 | 8,782 | - | 0 | Class A Common Stock | |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Global Sports Marketing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.94 per share. | 10 Feb 2025 | 345 | 37,310 (0%) | 0% | 70.9 | 24,474 | Class B Common Stock |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 762 | 8,020 | - | 0 | Class A Common Stock | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 762 | 1,525 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 762 | 2,287 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 762 | 7,258 | - | 0 | Class A Common Stock | |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2024 | 36,833 | 36,833 | - | - | Performance-Based Restricted Stock Units | |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2024 | 80,815 | 80,815 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2024 | 10,314 | 37,598 (0%) | 0% | 0 | Class B Common Stock | |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.85 per share. | 01 Aug 2024 | 2,094 | 27,284 (0%) | 0% | 73.9 | 154,642 | Class B Common Stock |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,917 | 2,917 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,167 | 2,167 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 7,710 (0%) | 0% | - | Common Stock | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 3,049 | 3,049 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 938 | 6,496 | - | 0 | Class A Common Stock | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 938 | 0 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 938 | 938 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 938 | 5,558 | - | 0 | Class A Common Stock | |
| Nike, Inc. - Ordinary Shar... | Miller Ann M. | EVP: Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.18 per share. | 12 Feb 2024 | 327 | 29,172 (0%) | 0% | 107.2 | 35,048 | Class B Common Stock |
| Dutch Bros Inc - Ordinary ... | M. Ann Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 938 | 1,876 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Miller Ann M. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 938 | 4,620 | - | 0 | Class A Common Stock | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2023 | 938 | 3,682 | - | 0 | Class A Common Stock | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2023 | 938 | 2,814 | - | - | Restricted Stock Units | |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.79 per share. | 11 Sep 2023 | 8,371 | 29,439 (0%) | 0% | 96.8 | 810,229 | Class B Common Stock |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 56,886 | 56,886 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 7,637 | 39,052 (0%) | 0% | 0 | Class B Common Stock | |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 109.40 per share. | 01 Aug 2023 | 1,242 | 37,810 (0%) | 0% | 109.4 | 135,875 | Class B Common Stock |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 3,752 | 3,752 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2023 | 2,744 | 2,744 | - | 0 | Class A Common Stock | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2023 | 2,744 | 0 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Ann M. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 2,744 | 2,744 | - | - | Restricted Stock Units | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 35,000 | 35,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 26,000 | 26,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 66,534 (0%) | 0% | - | Common Stock | |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.23 per share. | 10 Feb 2023 | 324 | 31,202 (0%) | 0% | 122.2 | 39,603 | Class B Common Stock |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 64,447 | 64,447 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Nike, Inc. - Ordinary Shar... | Ann M. Miller | EVP: Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 11,136 | 31,429 (0%) | 0% | 0 | Class B Common Stock | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 28,000 | 28,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 19,000 | 19,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 47,534 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 4,273 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 4,273 | 29,534 (0%) | 0% | - | Common Stock | |
| Puma Biotechnology Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 27,858 | 40,732 (0%) | 0% | 0 | COMMON STOCK | |
| Puma Biotechnology Inc | Ann C. Miller | Director | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 10 Jun 2021 | 12,874 | 12,874 (0%) | 0% | 11.4 | 147,156 | COMMON STOCK |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 27,000 | 27,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 18,000 | 18,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 25,261 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2021 | 4,274 | 4,273 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2021 | 4,274 | 16,561 (0%) | 0% | - | Common Stock | |
| Puma Biotechnology Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 25,748 | 25,748 (0%) | 0% | 0 | COMMON STOCK |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges